NEW YORK – Aniling said on Thursday that it has obtained CE-IVD marks for three of its cancer sequencing tests. The Barcelona, Spain-based diagnostics company said its chronic lymphocytic leukemia, ...
The company will focus in the coming months on negotiating a Series A round of €7 million to finance market entry, complete clinical validation and expand the product portfolio. Aniling, a biotech ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback